{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:24:49Z","timestamp":1787163889584,"version":"build-2736575974"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Surgery"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.asjsur.2023.05.170","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T17:05:06Z","timestamp":1686848706000},"page":"154-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Additive value of single intralesional bleomycin injection to propranolol in the management of proliferative infantile hemangioma"],"prefix":"10.1016","volume":"47","author":[{"given":"Lei","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.asjsur.2023.05.170_bib1","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.jaad.2021.08.019","article-title":"Infantile hemangioma. Part 1: epidemiology, pathogenesis, clinical presentation and assessment","volume":"85","author":"Bandera","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.asjsur.2023.05.170_bib2","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/1346-8138.14517","article-title":"Prolonged growth of infantile hemangioma after pulsed dye laser and oral propranolol treatment","volume":"45","author":"Kagami","year":"2018","journal-title":"J\u00a0Dermatol"},{"issue":"4","key":"10.1016\/j.asjsur.2023.05.170_bib3","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/PRS.0000000000007699","article-title":"Propranolol therapy in infantile hemangioma: it is not just about the beta","volume":"147","author":"Lee","year":"2021","journal-title":"Plast Reconstr Surg"},{"issue":"6","key":"10.1016\/j.asjsur.2023.05.170_bib4","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.jaad.2021.08.020","article-title":"Infantile hemangioma. Part 2: management","volume":"85","author":"Sebaratnam","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.asjsur.2023.05.170_bib5","first-page":"1419","article-title":"Oral propranolol for infantile hemangioma","volume":"372","author":"Steiner","year":"2015","journal-title":"J\u00a0Med"},{"issue":"2","key":"10.1016\/j.asjsur.2023.05.170_bib6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jaad.2015.04.053","article-title":"Propranolol treatment of infantile hemangiomas does not negatively affect psychomotor development","volume":"73","author":"Moyakine","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.asjsur.2023.05.170_bib7","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1097\/SCS.0000000000004152","article-title":"Intralesional bleomycin injection for propranolol-resistant hemangiomas","volume":"29","author":"Chang","year":"2018","journal-title":"J\u00a0Craniofac Surg"},{"key":"10.1016\/j.asjsur.2023.05.170_bib8","first-page":"12","article-title":"Low-dose sclerotherapy with lauromacrogol in the treatment of infantile hemangiomas: a retrospective analysis of 368 cases","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.asjsur.2023.05.170_bib9","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-3475","article-title":"Clinical practice guideline for the management of infantile hemangiomas","volume":"143","author":"Krowchuk","year":"2019","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.asjsur.2023.05.170_bib10","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.survophthal.2019.02.005","article-title":"Current treatment and management of infantile hemangiomas","volume":"64","author":"Satterfield","year":"2019","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"10.1016\/j.asjsur.2023.05.170_bib11","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s12519-019-00335-2","article-title":"Sleep disturbances as an adverse effect of propranolol use in children with infantile hemangioma.","volume":"16","author":"Xerfan","year":"2020","journal-title":"World Journal of Pediatrics"},{"issue":"1","key":"10.1016\/j.asjsur.2023.05.170_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-22787-8","article-title":"Intolerable side effects during propranolol therapy for infantile hemangioma: frequency, risk factors and management","volume":"8","author":"Ji","year":"2018","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.asjsur.2023.05.170_bib13","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s12519-019-00285-9","article-title":"Efficacy and adverse effects of oral propranolol in infantile hemangioma: a meta-analysis of comparative studies","volume":"15","author":"Yang","year":"2019","journal-title":"World Journal of Pediatrics"},{"issue":"4","key":"10.1016\/j.asjsur.2023.05.170_bib14","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1542\/peds.2015-2482","article-title":"Diagnosis and management of infantile hemangioma: executive summary","volume":"136","author":"Darrow","year":"2015","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.asjsur.2023.05.170_bib15","first-page":"409","article-title":"A\u00a0clinicopathological study to assess the role of intralesional sclerotherapy following propranolol treatment in infantile hemangioma.","volume":"14","author":"Kumar","year":"2021","journal-title":"J\u00a0Cutan Aesthetic Surg"},{"issue":"7","key":"10.1016\/j.asjsur.2023.05.170_bib16","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.ijom.2018.03.024","article-title":"Role of intralesional bleomycin and intralesional triamcinolone therapy in residual haemangioma following propranolol","volume":"47","author":"Pandey","year":"2018","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"3","key":"10.1016\/j.asjsur.2023.05.170_bib17","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1055\/s-2008-1071080","article-title":"A\u00a0new treatment with bleomycin for complicated cutaneous hemangioma in children","volume":"7","author":"Sarihan","year":"1997","journal-title":"Eur J Pediatr Surg"},{"issue":"1","key":"10.1016\/j.asjsur.2023.05.170_bib18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/bcp.12235","article-title":"The effectiveness of propranolol in treating infantile haemangiomas: a meta-analysis including 35 studies","volume":"78","author":"Lou","year":"2014","journal-title":"Br J Clin Pharmacol"}],"container-title":["Asian Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S101595842300828X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S101595842300828X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T17:33:54Z","timestamp":1760895234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S101595842300828X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S101595842300828X"],"URL":"https:\/\/doi.org\/10.1016\/j.asjsur.2023.05.170","relation":{},"ISSN":["1015-9584"],"issn-type":[{"value":"1015-9584","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Additive value of single intralesional bleomycin injection to propranolol in the management of proliferative infantile hemangioma","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.asjsur.2023.05.170","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Asian Surgical Association and Taiwan Robotic Surgery Association. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}